{"transactions":[{"id":1429045,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-19T09:00:08.000Z","date":"2024-08-15","kind":"purchase","planned":false,"acquired":true,"shares":84000,"price":5.9647,"value":501034.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $5.9100 to $6.0450 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."}],"balance_after":1223441,"source":{"system":"sec-edgar","filing":"0000950170-24-098286","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000095017024098286/ownership.xml","form_type":"4"}},{"id":1494919,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-03T16:30:08.000Z","date":"2024-05-31","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":6.0531,"value":151327.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $5.9400 to $6.1800 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."}],"balance_after":1139441,"source":{"system":"sec-edgar","filing":"0000950170-24-068023","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000095017024068023/ownership.xml","form_type":"4"}},{"id":1497637,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-30T17:04:07.000Z","date":"2024-05-29","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":5.2025,"value":130062.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $5.1300 to $5.2900 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."}],"balance_after":1114441,"source":{"system":"sec-edgar","filing":"0000950170-24-066745","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000095017024066745/ownership.xml","form_type":"4"}},{"id":1498968,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-29T16:33:18.000Z","date":"2024-05-28","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":5.0695,"value":253475.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.9600 to $5.2000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."}],"balance_after":1089441,"source":{"system":"sec-edgar","filing":"0000950170-24-065984","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000095017024065984/ownership.xml","form_type":"4"}},{"id":1518919,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-13T19:47:43.000Z","date":"2024-05-13","kind":"purchase","planned":false,"acquired":true,"shares":145000,"price":4.5378,"value":657981.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3800 to $4.6400 0inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."}],"balance_after":1039441,"source":{"system":"sec-edgar","filing":"0000950170-24-058986","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000095017024058986/ownership.xml","form_type":"4"}},{"id":1518918,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-13T19:47:43.000Z","date":"2024-05-10","kind":"purchase","planned":false,"acquired":true,"shares":83000,"price":4.5304,"value":376023.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average purchase price. These shares were bought in multiple transactions at prices ranging from $4.3300 to $4.7600 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote."}],"balance_after":894441,"source":{"system":"sec-edgar","filing":"0000950170-24-058986","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000095017024058986/ownership.xml","form_type":"4"}},{"id":1557479,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-29T21:55:07.000Z","date":"2022-11-15","kind":"sale","planned":true,"acquired":false,"shares":1700,"price":24.0167,"value":40828.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.6100 to $24.6000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1036441,"source":{"system":"sec-edgar","filing":"0000950170-24-038822","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000095017024038822/ownership.xml","form_type":"4"}},{"id":1557478,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-29T21:55:07.000Z","date":"2022-11-15","kind":"sale","planned":true,"acquired":false,"shares":200,"price":21.97,"value":4394.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":1038141,"source":{"system":"sec-edgar","filing":"0000950170-24-038822","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000095017024038822/ownership.xml","form_type":"4"}},{"id":1557477,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-29T21:55:07.000Z","date":"2022-11-15","kind":"sale","planned":true,"acquired":false,"shares":1600,"price":21.1813,"value":33890.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.6200 to $21.5400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1038341,"source":{"system":"sec-edgar","filing":"0000950170-24-038822","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000095017024038822/ownership.xml","form_type":"4"}},{"id":1557476,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-29T21:55:07.000Z","date":"2022-11-15","kind":"sale","planned":true,"acquired":false,"shares":46500,"price":20.12,"value":935580.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.55 to $20.4600 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1039941,"source":{"system":"sec-edgar","filing":"0000950170-24-038822","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000095017024038822/ownership.xml","form_type":"4"}},{"id":1908071,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-02T21:00:10.000Z","date":"2023-05-01","kind":"sale","planned":false,"acquired":false,"shares":2360,"price":25.9103,"value":61148.308,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.5400 to $26.1500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":861441,"source":{"system":"sec-edgar","filing":"0001209191-23-026796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000120919123026796/doc4.xml","form_type":"4"}},{"id":1908070,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-02T21:00:10.000Z","date":"2023-05-01","kind":"sale","planned":false,"acquired":false,"shares":7640,"price":25.037,"value":191282.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.5400 to $25.5000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":863801,"source":{"system":"sec-edgar","filing":"0001209191-23-026796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000120919123026796/doc4.xml","form_type":"4"}},{"id":1908069,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-02T21:00:10.000Z","date":"2023-04-28","kind":"sale","planned":false,"acquired":false,"shares":40000,"price":25.0066,"value":1000264.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.4100 to $25.3050 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":871441,"source":{"system":"sec-edgar","filing":"0001209191-23-026796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000120919123026796/doc4.xml","form_type":"4"}},{"id":1933828,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-31T21:00:15.000Z","date":"2023-03-30","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":25.8634,"value":1293170.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.5100 to $26.0700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":911441,"source":{"system":"sec-edgar","filing":"0001209191-23-021955","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000120919123021955/doc4.xml","form_type":"4"}},{"id":1979030,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-02T21:00:12.000Z","date":"2023-03-01","kind":"sale","acquired":false,"shares":12684,"price":21.36,"value":270930.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.9700 to $21.5200 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":961441,"source":{"system":"sec-edgar","filing":"0001209191-23-015075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000120919123015075/doc4.xml","form_type":"4"}},{"id":1979029,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-02T21:00:12.000Z","date":"2023-02-28","kind":"sale","acquired":false,"shares":37316,"price":21.54,"value":803786.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.4100 to $22.2250 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":974125,"source":{"system":"sec-edgar","filing":"0001209191-23-015075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000120919123015075/doc4.xml","form_type":"4"}},{"id":2035526,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-02T21:00:12.000Z","date":"2023-01-31","kind":"sale","acquired":false,"shares":11929,"price":23.19,"value":276633.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.8000 to $23.6000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1011441,"source":{"system":"sec-edgar","filing":"0001209191-23-006465","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000120919123006465/doc4.xml","form_type":"4"}},{"id":2042001,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common sotk","published_at":"2023-01-30T18:35:57.000Z","date":"2023-01-30","kind":"sale","acquired":false,"shares":1054,"price":24.5538,"value":25879.7052,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.3600 to $25.0600 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1023370,"source":{"system":"sec-edgar","filing":"0001209191-23-005547","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000120919123005547/doc4.xml","form_type":"4"}},{"id":2042000,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-30T18:35:57.000Z","date":"2023-01-30","kind":"sale","acquired":false,"shares":8803,"price":23.6751,"value":208411.9053,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.3500 to $24.3300 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1024424,"source":{"system":"sec-edgar","filing":"0001209191-23-005547","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000120919123005547/doc4.xml","form_type":"4"}},{"id":2041999,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-30T18:35:57.000Z","date":"2023-01-30","kind":"sale","acquired":false,"shares":28214,"price":22.9957,"value":648800.6798,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.3500 to $23.3400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1033227,"source":{"system":"sec-edgar","filing":"0001209191-23-005547","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000120919123005547/doc4.xml","form_type":"4"}},{"id":2086326,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-14T21:00:26.000Z","date":"2022-12-12","kind":"sale","acquired":false,"shares":25000,"price":24.183,"value":604575.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.8150 to $24.7050 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1061441,"source":{"system":"sec-edgar","filing":"0001209191-22-061323","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000120919122061323/doc4.xml","form_type":"4"}},{"id":2133422,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-21T20:00:11.000Z","date":"2022-10-20","kind":"sale","acquired":false,"shares":8742,"price":23.0194,"value":201235.5948,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.5000 to $23.3800 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1086441,"source":{"system":"sec-edgar","filing":"0001209191-22-054342","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000120919122054342/doc4.xml","form_type":"4"}},{"id":2133421,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-21T20:00:11.000Z","date":"2022-10-19","kind":"sale","acquired":false,"shares":10861,"price":23.3739,"value":253863.9279,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.2600 to $24.1900 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1095183,"source":{"system":"sec-edgar","filing":"0001209191-22-054342","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000120919122054342/doc4.xml","form_type":"4"}},{"id":2133420,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-21T20:00:11.000Z","date":"2022-10-19","kind":"sale","acquired":false,"shares":30397,"price":22.5917,"value":686719.9049,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.1600 to $23.1200 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1106044,"source":{"system":"sec-edgar","filing":"0001209191-22-054342","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000120919122054342/doc4.xml","form_type":"4"}},{"id":2157155,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-16T21:00:14.000Z","date":"2022-09-14","kind":"sale","acquired":false,"shares":22645,"price":23.2714,"value":526980.853,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"shares","element":"transactionShares","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.0900 to $23.4500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.0900 to $23.4500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1136441,"source":{"system":"sec-edgar","filing":"0001209191-22-050424","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000120919122050424/doc4.xml","form_type":"4"}},{"id":2157154,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-16T21:00:14.000Z","date":"2022-09-14","kind":"sale","acquired":false,"shares":27355,"price":22.8271,"value":624435.3205,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.0900 to $23.0800 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.0900 to $23.0800 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1159086,"source":{"system":"sec-edgar","filing":"0001209191-22-050424","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000120919122050424/doc4.xml","form_type":"4"}},{"id":2178059,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-19T20:00:09.000Z","date":"2022-08-18","kind":"sale","acquired":false,"shares":34046,"price":19.09,"value":649938.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.3400 to $19.2950 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1186441,"source":{"system":"sec-edgar","filing":"0001209191-22-046956","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000120919122046956/doc4.xml","form_type":"4"}},{"id":2178058,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-19T20:00:09.000Z","date":"2022-08-17","kind":"sale","acquired":false,"shares":15954,"price":19.54,"value":311741.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.0200 to $19.9000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1220487,"source":{"system":"sec-edgar","filing":"0001209191-22-046956","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000120919122046956/doc4.xml","form_type":"4"}},{"id":2204480,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-20T19:18:49.000Z","date":"2022-07-19","kind":"sale","acquired":false,"shares":20239,"price":16.1121,"value":326092.7919,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.62 to $16.54 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1236441,"source":{"system":"sec-edgar","filing":"0001567619-22-014272","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761922014272/doc1.xml","form_type":"4"}},{"id":2204479,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-20T19:18:49.000Z","date":"2022-07-18","kind":"sale","acquired":false,"shares":983,"price":16.4568,"value":16177.0344,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.39 to $16.51 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1256680,"source":{"system":"sec-edgar","filing":"0001567619-22-014272","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761922014272/doc1.xml","form_type":"4"}},{"id":2204478,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-20T19:18:49.000Z","date":"2022-07-18","kind":"sale","acquired":false,"shares":12978,"price":16.058,"value":208400.724,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.38 to $16.37 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1257663,"source":{"system":"sec-edgar","filing":"0001567619-22-014272","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761922014272/doc1.xml","form_type":"4"}},{"id":2206850,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-15T18:07:04.000Z","date":"2022-07-15","kind":"sale","acquired":false,"shares":8456,"price":16.1813,"value":136829.0728,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.67 to $16.47 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1270641,"source":{"system":"sec-edgar","filing":"0001567619-22-014078","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761922014078/doc1.xml","form_type":"4"}},{"id":2206849,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-15T18:07:04.000Z","date":"2022-07-14","kind":"sale","acquired":false,"shares":2800,"price":16.0333,"value":44893.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.60 to $16.25 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1279097,"source":{"system":"sec-edgar","filing":"0001567619-22-014078","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761922014078/doc1.xml","form_type":"4"}},{"id":2206848,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-15T18:07:04.000Z","date":"2022-07-13","kind":"sale","acquired":false,"shares":4544,"price":16.1275,"value":73283.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.82 to $16.3475 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1281897,"source":{"system":"sec-edgar","filing":"0001567619-22-014078","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761922014078/doc1.xml","form_type":"4"}},{"id":2225169,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-21T18:27:11.000Z","date":"2022-06-17","kind":"sale","acquired":false,"shares":29191,"price":13.734,"value":400909.194,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $13.52 to $14.00 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1286441,"source":{"system":"sec-edgar","filing":"0001567619-22-013208","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761922013208/doc1.xml","form_type":"4"}},{"id":2225168,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-21T18:27:11.000Z","date":"2022-06-16","kind":"sale","acquired":false,"shares":20809,"price":13.5794,"value":282573.7346,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $13.33 to $14.04 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1315632,"source":{"system":"sec-edgar","filing":"0001567619-22-013208","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761922013208/doc1.xml","form_type":"4"}},{"id":2253005,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T18:39:45.000Z","date":"2022-05-26","kind":"sale","acquired":false,"shares":19687,"price":15.7736,"value":310534.8632,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.33 to $16.015 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1336441,"source":{"system":"sec-edgar","filing":"0001567619-22-011883","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761922011883/doc1.xml","form_type":"4"}},{"id":2253004,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-27T18:39:45.000Z","date":"2022-05-25","kind":"sale","acquired":false,"shares":30313,"price":15.3506,"value":465322.7378,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.06 to $15.71 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1356128,"source":{"system":"sec-edgar","filing":"0001567619-22-011883","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761922011883/doc1.xml","form_type":"4"}},{"id":2335136,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-14T18:01:48.000Z","date":"2022-03-10","kind":"sale","acquired":false,"shares":2,"price":19.205,"value":38.41,"ownership":{"direct":false,"nature":"By J&A Group LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-22-006925","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761922006925/doc1.xml","form_type":"4"}},{"id":2335135,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-14T18:01:48.000Z","date":"2022-02-04","kind":"gift","acquired":false,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"balance_after":556183,"source":{"system":"sec-edgar","filing":"0001567619-22-006925","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761922006925/doc1.xml","form_type":"4"}},{"id":2430052,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-20T18:08:46.000Z","date":"2022-01-19","kind":"sale","acquired":false,"shares":32063,"price":18.9927,"value":608962.9401,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.4550 to $19.40 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1386441,"source":{"system":"sec-edgar","filing":"0001567619-22-001384","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761922001384/doc1.xml","form_type":"4"}},{"id":2430051,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-20T18:08:46.000Z","date":"2022-01-18","kind":"sale","acquired":false,"shares":6793,"price":20.0048,"value":135892.6064,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.75 to $20.355 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1418504,"source":{"system":"sec-edgar","filing":"0001567619-22-001384","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761922001384/doc1.xml","form_type":"4"}},{"id":2430050,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-20T18:08:46.000Z","date":"2022-01-18","kind":"sale","acquired":false,"shares":36144,"price":19.358,"value":699675.552,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.75 to $19.73 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1425297,"source":{"system":"sec-edgar","filing":"0001567619-22-001384","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761922001384/doc1.xml","form_type":"4"}},{"id":2456062,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-30T18:00:42.000Z","date":"2021-12-28","kind":"sale","acquired":false,"shares":1563,"price":16.8821,"value":26386.7223,"ownership":{"direct":false,"nature":"By J&A Group LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.59 to $17.39 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company."}],"balance_after":2,"source":{"system":"sec-edgar","filing":"0001567619-21-022714","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921022714/doc1.xml","form_type":"4"}},{"id":2458467,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-27T20:09:36.000Z","date":"2021-12-27","kind":"sale","acquired":false,"shares":6437,"price":17.4581,"value":112377.7897,"ownership":{"direct":false,"nature":"By J&A Group LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.25 to  $17.615 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company."}],"balance_after":1565,"source":{"system":"sec-edgar","filing":"0001567619-21-022541","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921022541/doc1.xml","form_type":"4"}},{"id":2458466,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-27T20:09:36.000Z","date":"2021-12-23","kind":"sale","acquired":false,"shares":12610,"price":16.904,"value":213159.44,"ownership":{"direct":false,"nature":"By J&A Group LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.50 to $17.29 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company."}],"balance_after":8002,"source":{"system":"sec-edgar","filing":"0001567619-21-022541","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921022541/doc1.xml","form_type":"4"}},{"id":2458465,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-27T20:09:36.000Z","date":"2021-12-22","kind":"sale","acquired":false,"shares":23390,"price":16.2764,"value":380704.996,"ownership":{"direct":false,"nature":"By J&A Group LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.59 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company."}],"balance_after":20612,"source":{"system":"sec-edgar","filing":"0001567619-21-022541","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921022541/doc1.xml","form_type":"4"}},{"id":2460724,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T19:03:33.000Z","date":"2021-12-21","kind":"sale","acquired":false,"shares":1403,"price":16.3597,"value":22952.6591,"ownership":{"direct":false,"nature":"By J&A Group LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.32 to $16.38 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company."}],"balance_after":44002,"source":{"system":"sec-edgar","filing":"0001567619-21-022459","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921022459/doc1.xml","form_type":"4"}},{"id":2460723,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T19:03:33.000Z","date":"2021-12-21","kind":"sale","acquired":false,"shares":13478,"price":16.1215,"value":217285.577,"ownership":{"direct":false,"nature":"By J&A Group LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.32 to $16.31 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company."}],"balance_after":45405,"source":{"system":"sec-edgar","filing":"0001567619-21-022459","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921022459/doc1.xml","form_type":"4"}},{"id":2460722,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T19:03:33.000Z","date":"2021-12-20","kind":"other","acquired":true,"shares":406183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Includes pro rata distribution from J&A Group, LLC."}],"balance_after":1461441,"source":{"system":"sec-edgar","filing":"0001567619-21-022459","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921022459/doc1.xml","form_type":"4"}},{"id":2460721,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T19:03:33.000Z","date":"2021-12-20","kind":"other","acquired":true,"shares":406183,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Includes pro rata distribution from J&A Group, LLC."}],"balance_after":1006183,"source":{"system":"sec-edgar","filing":"0001567619-21-022459","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921022459/doc1.xml","form_type":"4"}},{"id":2460720,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T19:03:33.000Z","date":"2021-12-20","kind":"other","acquired":false,"shares":270789,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By J&A Group LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Pro rata distribution from J&A Group, LLC to member."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company."}],"balance_after":58883,"source":{"system":"sec-edgar","filing":"0001567619-21-022459","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921022459/doc1.xml","form_type":"4"}},{"id":2460719,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T19:03:33.000Z","date":"2021-12-20","kind":"other","acquired":false,"shares":270789,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By J&A Group LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Pro rata distribution from J&A Group, LLC to member."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company."}],"balance_after":329672,"source":{"system":"sec-edgar","filing":"0001567619-21-022459","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921022459/doc1.xml","form_type":"4"}},{"id":2460718,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T19:03:33.000Z","date":"2021-12-20","kind":"other","acquired":false,"shares":406183,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By J&A Group LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Pro rata distribution from J&A Group, LLC to member."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company."}],"balance_after":600461,"source":{"system":"sec-edgar","filing":"0001567619-21-022459","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921022459/doc1.xml","form_type":"4"}},{"id":2460717,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T19:03:33.000Z","date":"2021-12-20","kind":"other","acquired":false,"shares":406183,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By J&A Group LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Pro rata distribution from J&A Group, LLC to member."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company."}],"balance_after":1006644,"source":{"system":"sec-edgar","filing":"0001567619-21-022459","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921022459/doc1.xml","form_type":"4"}},{"id":2460716,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T19:03:33.000Z","date":"2021-12-20","kind":"sale","acquired":false,"shares":400,"price":16.2988,"value":6519.52,"ownership":{"direct":false,"nature":"By J&A Group LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.275 to  $16.32 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company."}],"balance_after":1412827,"source":{"system":"sec-edgar","filing":"0001567619-21-022459","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921022459/doc1.xml","form_type":"4"}},{"id":2460715,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T19:03:33.000Z","date":"2021-12-20","kind":"sale","acquired":false,"shares":15719,"price":15.6872,"value":246587.0968,"ownership":{"direct":false,"nature":"By J&A Group LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from  $15.205 to $16.10 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company."}],"balance_after":1413227,"source":{"system":"sec-edgar","filing":"0001567619-21-022459","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921022459/doc1.xml","form_type":"4"}},{"id":2465606,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-17T17:51:58.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":474,"price":16.8643,"value":7993.6782,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $16.69 to $17.02 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1055258,"source":{"system":"sec-edgar","filing":"0001567619-21-022289","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921022289/doc1.xml","form_type":"4"}},{"id":2465605,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-17T17:51:58.000Z","date":"2021-12-15","kind":"sale","acquired":false,"shares":74526,"price":16.0568,"value":1196649.0768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $15.63 to  $16.61 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1055732,"source":{"system":"sec-edgar","filing":"0001567619-21-022289","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921022289/doc1.xml","form_type":"4"}},{"id":2494994,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T20:49:31.000Z","date":"2021-11-24","kind":"sale","acquired":false,"shares":17000,"price":17.8257,"value":303036.9,"ownership":{"direct":false,"nature":"J&A Group, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.12 to $18.0750 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company."}],"balance_after":1428946,"source":{"system":"sec-edgar","filing":"0001567619-21-021185","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921021185/doc1.xml","form_type":"4"}},{"id":2494993,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T20:49:31.000Z","date":"2021-11-23","kind":"sale","acquired":false,"shares":1736,"price":18.41,"value":31959.76,"ownership":{"direct":false,"nature":"J&A Group, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.21 to $18.50 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company."}],"balance_after":1445946,"source":{"system":"sec-edgar","filing":"0001567619-21-021185","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921021185/doc1.xml","form_type":"4"}},{"id":2494992,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T20:49:31.000Z","date":"2021-11-23","kind":"sale","acquired":false,"shares":15264,"price":17.3695,"value":265128.048,"ownership":{"direct":false,"nature":"J&A Group, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $17.04 to $17.66 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company."}],"balance_after":1447682,"source":{"system":"sec-edgar","filing":"0001567619-21-021185","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921021185/doc1.xml","form_type":"4"}},{"id":2494991,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T20:49:31.000Z","date":"2021-11-22","kind":"sale","acquired":false,"shares":146,"price":19.39,"value":2830.94,"ownership":{"direct":false,"nature":"J&A Group, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.32 to $19.54 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company."}],"balance_after":1462946,"source":{"system":"sec-edgar","filing":"0001567619-21-021185","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921021185/doc1.xml","form_type":"4"}},{"id":2494990,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-24T20:49:31.000Z","date":"2021-11-22","kind":"sale","acquired":false,"shares":15854,"price":18.51,"value":293457.54,"ownership":{"direct":false,"nature":"J&A Group, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.13 to $19.09 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company."}],"balance_after":1463092,"source":{"system":"sec-edgar","filing":"0001567619-21-021185","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921021185/doc1.xml","form_type":"4"}},{"id":2506676,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-17T20:32:31.000Z","date":"2021-11-12","kind":"gift","acquired":false,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"Gift transfer to reporting person's spouse."}],"balance_after":1130258,"source":{"system":"sec-edgar","filing":"0001567619-21-020693","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921020693/doc1.xml","form_type":"4"}},{"id":2506675,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-17T20:32:31.000Z","date":"2021-10-27","kind":"gift","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"Gift transfer to a second natural person."}],"balance_after":1730258,"source":{"system":"sec-edgar","filing":"0001567619-21-020693","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921020693/doc1.xml","form_type":"4"}},{"id":2506674,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-17T20:32:31.000Z","date":"2021-10-27","kind":"gift","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Gift transfer to a natural person."}],"balance_after":1930258,"source":{"system":"sec-edgar","filing":"0001567619-21-020693","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921020693/doc1.xml","form_type":"4"}},{"id":2506673,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-17T20:32:31.000Z","date":"2021-11-17","kind":"sale","acquired":false,"shares":25000,"price":20.33,"value":508250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.87 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2130258,"source":{"system":"sec-edgar","filing":"0001567619-21-020693","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921020693/doc1.xml","form_type":"4"}},{"id":2506672,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-17T20:32:31.000Z","date":"2021-11-16","kind":"sale","acquired":false,"shares":25000,"price":20.86,"value":521500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.46 to $21.18 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2155258,"source":{"system":"sec-edgar","filing":"0001567619-21-020693","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921020693/doc1.xml","form_type":"4"}},{"id":2506671,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-17T20:32:31.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":5515,"price":21.41,"value":118076.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.99 to $21.87 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2180258,"source":{"system":"sec-edgar","filing":"0001567619-21-020693","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921020693/doc1.xml","form_type":"4"}},{"id":2506670,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-17T20:32:31.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":19485,"price":20.41,"value":397688.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.98 to $20.95 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2185773,"source":{"system":"sec-edgar","filing":"0001567619-21-020693","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000156761921020693/doc1.xml","form_type":"4"}},{"id":2735688,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-04-29T21:09:19.000Z","date":"2021-04-27","kind":"exercise","acquired":false,"shares":569067,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"J&A Group, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":569067},"source":{"system":"sec-edgar","filing":"0000899243-21-017461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000089924321017461/doc4.xml","form_type":"4"}},{"id":2735687,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-04-29T21:09:19.000Z","date":"2021-04-27","kind":"exercise","acquired":false,"shares":399632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":399633},"source":{"system":"sec-edgar","filing":"0000899243-21-017461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000089924321017461/doc4.xml","form_type":"4"}},{"id":2735686,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-04-29T21:09:19.000Z","date":"2021-04-27","kind":"other","acquired":true,"shares":13169,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"J&A Group, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company."}],"balance_after":569067,"derivative":{"underlying":"Common Stock","underlying_shares":13169},"source":{"system":"sec-edgar","filing":"0000899243-21-017461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000089924321017461/doc4.xml","form_type":"4"}},{"id":2735685,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2021-04-29T21:09:19.000Z","date":"2021-04-27","kind":"other","acquired":true,"shares":9250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend."}],"balance_after":399633,"derivative":{"underlying":"Common Stock","underlying_shares":9250},"source":{"system":"sec-edgar","filing":"0000899243-21-017461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000089924321017461/doc4.xml","form_type":"4"}},{"id":2735684,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-29T21:09:19.000Z","date":"2021-04-27","kind":"exercise","acquired":true,"shares":569067,"ownership":{"direct":false,"nature":"J&A Group, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"James T. Treace and his spouse are managing members of J&A Group, LLC, a Florida limited liability company."}],"balance_after":1478946,"source":{"system":"sec-edgar","filing":"0000899243-21-017461","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000089924321017461/doc4.xml","form_type":"4"}},{"id":2735683,"issuer":{"id":5943,"kind":"organization","name":"TREACE MEDICAL CONCEPTS, INC.","symbol":"TMCI"},"owners":[{"id":88223,"kind":"person","name":"TREACE JAMES T","position":1,"cik":"0001185191","reported_name":"TREACE JAMES T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-29T21:09:19.000Z","date":"2021-04-27","kind":"exercise","acquired":true,"shares":399633,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date."}],"balance_after":2205258,"source":{"system":"sec-edgar","filing":"0000899243-21-017461","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1185191/000089924321017461/doc4.xml","form_type":"4"}}]}